AK

Anjan Kumar Roy

Active Director Director DIN 01032834
DIN 01032834 First appointment Nov 1992 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Nov 1992
Shareholding value •••• Premium profile

About Anjan Kumar Roy

Data last updated:

Anjan Kumar Roy is a Director at Flowchem Pharma Private Limited (since 2021), Whole-Time Director at Ray Life Sciences Private Limited (since 1992) and Director at Trroy Life Sciences Private Limited (since 2010). The companies operate in Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹50.12 Cr; the largest is Flowchem Pharma Private Limited at ₹37.16 Cr (FY 2025). Earlier, Anjan Kumar Roy was a Director at Natural Capsules Limited (2018–2022) and Director at R.L.Fine Chem Private Limited (2011–2016).

DIN 01032834
Primary Designation Director
Industry Pharma
First Appointment 20 Nov 1992
Oldest Company Age 35 yrs
Largest company Flowchem Pharma Private Limited · ₹37.16 Cr (FY 2025)
Combined revenue ₹50.12 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Flowchem Pharma Private Limited U24304KA2018PTC118418
Director06 Sep 20212018₹37.16 Cr (FY 2025)Active
Ray Life Sciences Private Limited U24111KA1991PTC012343
Whole-Time Director20 Nov 19921991₹10.79 Cr (FY 2024)Active
Trroy Life Sciences Private Limited U24230KA2010PTC054629
Director30 Jul 20102010₹2.18 Cr (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Natural Capsules Limited L85110KA1993PLC014742
Director30 Jul 20181993₹170 Cr (FY 2025)Active
R.L.Fine Chem Private Limited U24100KA2011PTC059846
Director02 Aug 20112011₹360 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ray Life Sciences Private Limited
Trroy Life Sciences Private Limited
Flowchem Pharma Private Limited
Natural Capsules Limited
Premium access

Shareholding and investment profile for Anjan Kumar Roy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anjan Kumar Roy

Anjan Kumar Roy currently holds 3 directorships: Flowchem Pharma Private Limited (Director, since 06 Sep 2021, revenue ₹37.16 Cr (FY 2025)); Ray Life Sciences Private Limited (Whole-Time Director, since 20 Nov 1992, revenue ₹10.79 Cr (FY 2024)); Trroy Life Sciences Private Limited (Director, since 30 Jul 2010, revenue ₹2.18 Cr (FY 2024)).

Anjan Kumar Roy was first appointed on 20 Nov 1992 as Whole-Time Director at Ray Life Sciences Private Limited. The most recent appointment on record is 06 Sep 2021 at Flowchem Pharma Private Limited.

The 3 current companies of Anjan Kumar Roy that report revenue have a combined latest revenue of ₹50.12 Cr: Flowchem Pharma Private Limited ₹37.16 Cr (FY 2025); Ray Life Sciences Private Limited ₹10.79 Cr (FY 2024); Trroy Life Sciences Private Limited ₹2.18 Cr (FY 2024).

Anjan Kumar Roy held 2 earlier board appointments: Natural Capsules Limited (Director, 30 Jul 2018 to 10 Aug 2022); R.L.Fine Chem Private Limited (Director, 02 Aug 2011 to 26 Aug 2016).

The current boards of Anjan Kumar Roy's companies include Dipak Kumar Chaudhary (Flowchem Pharma Private Limited), Parthasarathi Pal (Flowchem Pharma Private Limited), Trishna Roy (Flowchem Pharma Private Limited), Sumitra Roy (Ray Life Sciences Private Limited), Tanushree Roy (Ray Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available